Legal & General Group Plc - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 76 filers reported holding KURA ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$488,696
-14.0%
53,585
-0.2%
0.00%
Q2 2023$568,242
+36.0%
53,709
+57.2%
0.00%
Q1 2023$417,912
+50.5%
34,171
+52.7%
0.00%
Q4 2022$277,650
-5.6%
22,373
+4.0%
0.00%
Q3 2022$294,000
-21.8%
21,516
+5.1%
0.00%
Q2 2022$376,000
+21.7%
20,467
+6.4%
0.00%
Q1 2022$309,000
+14.4%
19,2420.0%0.00%
Q4 2021$270,000
-25.0%
19,2420.0%0.00%
Q3 2021$360,000
+113.0%
19,242
+137.0%
0.00%
Q2 2021$169,000
-39.2%
8,119
-17.7%
0.00%
Q1 2021$278,000
-9.4%
9,861
+4.8%
0.00%
Q4 2020$307,000
+17.6%
9,410
+10.7%
0.00%
Q3 2020$261,000
+48.3%
8,503
-21.4%
0.00%
Q2 2020$176,000
+175.0%
10,813
+61.2%
0.00%
Q1 2020$64,000
-40.7%
6,706
-14.6%
0.00%
Q4 2019$108,000
+8.0%
7,857
+19.3%
0.00%
Q3 2019$100,000
-13.8%
6,586
+11.6%
0.00%
Q2 2019$116,000
+27.5%
5,901
+7.4%
0.00%
Q1 2019$91,000
+24.7%
5,492
+6.1%
0.00%
Q4 2018$73,000
-1.4%
5,175
+21.7%
0.00%
Q3 2018$74,000
+8.8%
4,252
+13.9%
0.00%
Q2 2018$68,000
-4.2%
3,733
-2.0%
0.00%
Q1 2018$71,000
-10.1%
3,811
-24.6%
0.00%
Q4 2017$79,000
+61.2%
5,055
+53.0%
0.00%
Q3 2017$49,000
+145.0%
3,305
+56.6%
0.00%
Q2 2017$20,0002,1100.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2017
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders